Maya Williams

High Impact

Assistant Professor

University of Arkansas for Medical Sciences

faculty

30 h-index 139 pubs 3,289 cited

Research Areas

SARS-CoV-2 and COVID-19 Research Immune Response and Inflammation Microbial infections and disease research Innovative Teaching and Learning Methods Teacher Education and Leadership Studies Child and Adolescent Psychosocial and Emotional Development Health disparities and outcomes Meta-analysis and systematic reviews

Links

ORCID Lab Website

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Maya Williams' research focuses on understanding and improving immune responses to viral pathogens and exploring educational strategies for student success. She has investigated the immunogenicity of various SARS-CoV-2 vaccines, including adjuvanted inactivated vaccines and spike protein DNA vaccines in mouse models. Her work also includes the development of pseudovirus-based assays for measuring antibody-mediated neutralization of SARS-CoV-2.

Beyond virology, Williams' scholarship extends to educational practices. She has examined teacher perspectives on restorative practices and identified programmatic elements that foster positive relational development in schools. Additionally, her research includes a scoping review of colorism in educational settings, analyzing its impact on the academic, social, and emotional experiences of students of color. She also explores predictive models for group work's effect on student math anxiety.

With a h-index of 30 and over 3,200 citations from 139 publications, Williams is recognized as a highly cited researcher. Her active lab website and recent publications indicate ongoing engagement in her research areas.

Metrics

h-index: 30
Publications: 139
Citations: 3,289

Selected Publications

Consultant perception of the feasibility and effectiveness of infant and early childhood mental health consultation services provided virtually to early care and education (2025) DOI
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025) DOI
A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023) DOI
HPV-associated Vulvar Intraepithelial Carcinoma With Sebaceous Differentiation: Report of 2 Cases (2022) DOI
Comparison of Chloroprocaine Versus Lidocaine With Epinephrine, Sodium Bicarbonate, and Fentanyl for Epidural Extension Anesthesia in Elective Cesarean Delivery: A Randomized, Triple-blind, Noninferiority Study (2022) DOI